Geode Capital Management
INBX

Geode Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Geode Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-704,825
Closed -$24.6M – 4723
2024
Q1 		$24.6M Buy
704,825
+17,465
+3% +$637K ﹤0.01% 1795
2023
Q4 		$26.1M Buy
687,360
+41,201
+6% +$883K ﹤0.01% 1750
2023
Q3 		$11.9M Sell
646,159
-12,864
-2% -$269K ﹤0.01% 2157
2023
Q2 		$17.1M Buy
659,023
+49,206
+8% +$1.15M ﹤0.01% 1962
2023
Q1 		$11.5M Buy
609,817
+34,120
+6% +$793K ﹤0.01% 2165
2022
Q4 		$14.2M Buy
575,697
+78,890
+16% +$2.32M ﹤0.01% 2016
2022
Q3 		$8.92M Buy
496,807
+63,688
+15% +$1.15M ﹤0.01% 2334
2022
Q2 		$4.92M Sell
433,119
-17,321
-4% -$255K ﹤0.01% 2706
2022
Q1 		$10M Buy
450,440
+20,558
+5% +$525K ﹤0.01% 2342
2021
Q4 		$18.8M Sell
429,882
-16,341
-4% -$653K ﹤0.01% 2000
2021
Q3 		$14.9M Buy
446,223
+126,382
+40% +$3.85M ﹤0.01% 2169
2021
Q2 		$8.8M Buy
319,841
+169,371
+113% +$3.53M ﹤0.01% 2548
2021
Q1 		$3.02M Buy
150,470
+920
+0.6% +$26.9K ﹤0.01% 3048
2020
Q4 		$4.93M Buy
149,550
+129,465
+645% +$3.44M ﹤0.01% 2613
2020
Q3 		$361K Buy
+20,085
New +$364K ﹤0.01% 3533

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Geode Capital Management's INBX Position: Q2 2024 in Review

Geode Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 704,825 shares — an estimated $24.6M sold.

Geode Capital Management first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $26.1M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Geode Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Geode Capital Management sold 704,825 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $24.6M.
  • Geode Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Geode Capital Management's Inhibrx, Inc. Common Stock position peaked at $26.1M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.